Norris Perne & French’s iShares Biotechnology ETF IBB Stock Holding History

Norris Perne & French’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,950	Closed	-$208K	–	142
2018 Q1	$208K	Hold	1,950	–	–	0.03%	138
2017 Q4	$208K	Hold	1,950	–	–	0.03%	143
2017 Q3	$217K	Hold	1,950	–	–	0.03%	144
2017 Q2	$202K	Sell	1,950 -750	-28%	-$73.9K	0.03%	148
2017 Q1	$264K	Buy	+2,700	New	+$258K	0.05%	130
2016 Q1	–	Sell	-1,800	Closed	-$203K	–	151
2015 Q4	$203K	Buy	+1,800	New	+$195K	0.04%	147
2015 Q3	–	Sell	-1,800	Closed	-$221K	–	151
2015 Q2	$221K	Hold	1,800	–	–	0.04%	148
2015 Q1	$206K	Buy	+1,800	New	+$199K	0.04%	155
2014 Q2	–	Sell	-4,497	Closed	-$354K	–	172
2014 Q1	$354K	Buy	+4,497	New	+$375K	0.07%	118

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Norris Perne & French's IBB Position: Q2 2018 in Review

Norris Perne & French sold out of iShares Biotechnology ETF (IBB) in Q2 2018, closing a stake of 1,950 shares — an estimated $208K sold.

Norris Perne & French first reported a position in IBB in Q1 2014 and held it in 9 quarters. The position peaked at $354K in Q1 2014. 608 funds tracked by Wall St. Rank hold IBB as of Q2 2018.

Norris Perne & French reported no remaining iShares Biotechnology ETF position as of Q2 2018 after selling out during the quarter.
Norris Perne & French sold 1,950 iShares Biotechnology ETF shares in Q2 2018, an estimated $208K.
Norris Perne & French first reported a position in iShares Biotechnology ETF in Q1 2014 and held it in 9 quarters.
Norris Perne & French's iShares Biotechnology ETF position peaked at $354K in Q1 2014.
608 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2018.

Based on Norris Perne & French's 13F filing for Q2 2018, filed 24 Jul 2018.